Olema Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $23.1M | $276.9M | $68.5M |
| FY2024 | $42.0M | $451.0M | $139.5M |
| FY2025 | $54.9M | $533.4M | $48.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $23.1M | $276.9M | $68.5M |
| FY2024 | $42.0M | $451.0M | $139.5M |
| FY2025 | $54.9M | $533.4M | $48.3M |